Of the 96 patients diagnosed with established AAV at the Department of Rheumatology and Nephrology, University Hospital, Umeå, Sweden, 78 participated in this study with a plasma sample. Medical records were reviewed to identify the time-point for onset and the AAV diagnosis [24]. The mean (SD) age at sampling was 64.3 (19.1), 52.6% were women, and the disease duration (mean (SD)) was 9.7 (7.1 years). During the disease period, the established AAV patients were treated according to guidelines [26] (Table 1). Thus, during active disease, 88% were treated with pulses of corticosteroids and 81% with cyclophosphamide, and the remainder received azathioprine or methotrexate. In addition, 28% were given antibiotic prophylaxis (trimethoprim-sulfamethoxazole) during active disease. In 10% of the cases with a relapse, rituximab was added. In most cases, maintenance therapy was oral prednisolone (5–12.5 mg daily) plus a cytotoxic drug (e.g., methotrexate/azathioprine/mofetil mycophenolate).
Information on dental status was retrieved from the Swedish quality register on caries and periodontitis (SKaPa, www.skapareg.se, accessed on 14 December 2021) [27]. Data on the number of teeth, cause of tooth loss, probing pocket depth (PPD), and caries or restoration per tooth (third molars excluded) were available from 2010 to 2020 [28]. For periodontal status, the number of teeth with PPD ≥ 6 mm was calculated as described previously [29], and for caries, the Decayed, Missing, Filled index, which gives the sum of caries-affected tooth surfaces. Information on PPD was available for 61 established AAV cases, and for these, information from the dental visit closest to the AAV diagnosis was retrieved (median difference 3.0 years after AAV diagnosis (quartile limits 0 and 8.5 years). Caries status was available for 59 cases and similarly, the visit closest to the AAV diagnosis was kept (median difference 3 years after AAV diagnosis (quartile limits 0 and 9.0 years). Dental status was also compiled for three controls per case, matched for sex, age, and birth year, and for a group of patients with RA [30] with dental data from the same year as the RA diagnosis (n = 557, mean age (SD) 57.7 (15.9) years, 72.4% women, 56.4% ever smoker). Smoking status was classified as being a never or ever (current and former) smoker.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.